Form 4: Agenus CEO Garo Armen Takes Salary in Stock

Agenus Inc. CEO Garo H. Armen acquired 3,780 shares of common stock at $3.91 per share as part of his salary, opting for equity in lieu of cash.

Summary

• Garo H. Armen, Chairman and Chief Executive Officer of Agenus Inc., acquired 3,780 shares of the company's common stock.
• The transaction occurred on January 9, 2026, with shares priced at $3.91 each, which was the closing price on that date.
• This acquisition represents the net amount of Dr. Armen's salary for the pay period ending January 9, 2026, paid in stock instead of cash, at his request and with Compensation Committee approval.
• The shares issued are fully vested on the date of issuance, in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive plan.
• Following this transaction, Dr. Armen directly beneficially owns 311,123 shares of common stock.
• Dr. Armen also indirectly beneficially owns 31,298 shares held in his IRA accounts and 28,950 shares through the Garo Armen 2020 2 Year AG GRAT and Pixie Partners, where he is a trustee or general partner.

Sentiment

Score: 8

Explanation: The CEO's choice to receive salary in company stock, rather than cash, is a strong positive signal, indicating high confidence in the company's future performance and direct alignment with shareholder interests.

Positives

• CEO Garo H. Armen's decision to receive salary in stock demonstrates strong alignment with shareholder interests and confidence in the company's future prospects.
• The shares acquired are fully vested upon issuance, indicating immediate ownership and commitment.

Future Outlook

NA

Management Comments

• "At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash."

Industry Context

The practice of executives, particularly CEOs, opting to receive compensation in company stock rather than cash is a common strategy across various industries, especially in growth-oriented sectors like biotechnology. This move is often interpreted as a strong signal of management's belief in the company's long-term value and commitment to aligning their financial interests with those of shareholders.

Comparison to Industry Standards

• Many executives in the biotechnology sector, similar to those at companies like Regeneron Pharmaceuticals (REGN) or Moderna (MRNA), frequently choose equity compensation to align their incentives with long-term shareholder value creation.
• This type of insider transaction, where a CEO takes salary in stock, is generally viewed favorably by investors as it demonstrates a higher level of commitment and confidence compared to executives who solely opt for cash compensation.

Related Party Transactions

• The acquisition of common stock by Garo H. Armen as salary constitutes a related party transaction between the company and its Chairman and CEO.
• Indirect beneficial ownership through the Garo Armen 2020 2 Year AG GRAT and Pixie Partners also represents dealings where Dr. Armen has a pecuniary interest or investment authority.

Stakeholder Impact

• Shareholders: Likely to view this as a positive signal, indicating strong management confidence and alignment of interests.
• Employees: No direct impact on general employees is indicated by this filing.
• Customers/Suppliers/Creditors: No direct impact on these stakeholders is indicated by this filing.

Key Dates

Recommendation

The CEO's decision to accept salary in company stock, rather than cash, signals strong confidence in Agenus Inc.'s future prospects and aligns management's financial interests directly with those of shareholders. This insider buying activity, particularly from the top executive, is often interpreted as a bullish indicator, suggesting potential for future stock appreciation. While a single Form 4 is not a complete investment thesis, it provides a compelling signal of internal belief in the company's value.

Keywords

Agenus, AGEN, Form 4, insider transaction, stock compensation, CEO, Garo Armen, equity incentive, beneficial ownership